Authors:
LATTANZI SC
TOSTESON T
CHERTOFF J
MAURER LH
ODONNELL J
LEMARBRE PJ
MOTT L
DELPRETE SA
FORCIER RJ
ERNSTOFF MS
Citation: Sc. Lattanzi et al., DACARBAZINE, CISPLATIN AND CARMUSTINE, WITH OR WITHOUT TAMOXIFEN, FORMETASTATIC MELANOMA - 5-YEAR FOLLOW-UP, Melanoma research, 5(5), 1995, pp. 365-369
Authors:
LO KMS
BEER M
CONKLING A
KOSONEN P
GRANN VR
ERICHSON RB
WEINSTEIN PL
DELPRETE SA
COHEN NS
XISTRIS D
BAR MH
Citation: Kms. Lo et al., PACLITAXEL (TXL) PLUS CYCLOPHOSPHAMIDE (CTX) PLUS G-CSF AND ETOPOSIDE(VP) PLUS CTX PLUS G-CSF ARE SIMILAR IN THEIR ABILITY TO MOBILIZE PERIPHERAL-BLOOD PROGENITOR CELLS (PBPC) IN PATIENTS WITH BREAST-CANCER UNDERGOING HIGH-DOSE CHEMOTHERAPY (HDC), Blood, 86(10), 1995, pp. 3934-3934
Authors:
MURREN JR
DURIVAGE HJ
ROSENBERG AH
CHEN YT
DELPRETE SA
MURPHY GJ
BUZAID AC
HAIT WN
Citation: Jr. Murren et al., CISPLATIN, DOXORUBICIN, MITOMYCIN-C, AND 5-FLUOROURACIL FOR THE TREATMENT OF METASTATIC NONSMALL CELL LUNG-CANCER - LIMITED ACTIVITY OF AN AGGRESSIVE CHEMOTHERAPY REGIMEN, American journal of clinical oncology, 17(3), 1994, pp. 239-241